CCM
MSACW

Consonance Capital Management’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Consonance Capital Management’s Portfolio MSACW Stock Details MSACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,331
Closed -$24K – 11
2021
Q4 		$24K Hold
33,331
– – 0.02% 15
2021
Q3 		$24K Hold
33,331
– – 0.01% 17
2021
Q2 		$34K Buy
+33,331
New +$26.4K ﹤0.01% 32

Other funds holding MSACW

DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

Consonance Capital Management's MSACW Position: Q1 2022 in Review

Consonance Capital Management sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2022, closing a stake of 33,331 shares — an estimated $24K sold.

Consonance Capital Management first reported a position in MSACW in Q2 2021 and held it in 3 quarters. The position peaked at $34K in Q2 2021. 16 funds tracked by Wall St. Rank hold MSACW as of Q1 2022.

  • Consonance Capital Management reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2022 after selling out during the quarter.
  • Consonance Capital Management sold 33,331 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2022, an estimated $24K.
  • Consonance Capital Management first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 3 quarters.
  • Consonance Capital Management's Medicus Sciences Acquisition Corp. Warrant position peaked at $34K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2022.

Based on Consonance Capital Management's 13F filing for Q1 2022, filed 16 May 2022.